For patients experiencing acute coronary syndrome (SCA) while on statin therapy, the first consideration should be the current drug and dosage: for those with a history of confirmed statin intolerance and SCA, prescribing ezetimibe 10 mg/day and a PCSK9 inhibitor is reasonable. This evidence concerns the gene PCSK9 and autosomal dominant cerebellar ataxia.